Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Global Nebulizer Market by Type (Jet Nebulizer, Mesh Nebulizer, Ultrasonic Nebulizer), Distribution Channel (Offline, Online), Application, End-user - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The Nebulizer Market size was estimated at USD 2.51 billion in 2023, USD 2.68 billion in 2024, and is expected to grow at a CAGR of 6.77% to reach USD 3.97 billion by 2030.
The rising prevalence of respiratory diseases across the globe, owing to growing pollution levels and the rising smoking population, fosters the adoption of nebulizers. The risk of infection associated with nebulizer use, particularly in hospitals and clinics, poses a significant challenge to the nebulizer market. Moreover, ongoing R&D efforts aimed at producing nebulizers that are faster, more efficient, and less prone to infections provide opportunities for product innovation and differentiation. Additionally, technological advancements leading to more portable, efficient, and user-friendly nebulizer devices are expected to raise the adoption of these devices in homecare settings.
Regional Insights
The rising incidence of chronic respiratory diseases in the Americas, such as chronic obstructive pulmonary disease (COPD) and asthma, has been generating a significant adoption of nebulizers. The regional market exhibits robust growth owing to high healthcare expenditure, advanced healthcare infrastructure, and the strong presence of major nebulizer manufacturers. In Europe, a high prevalence of respiratory diseases, well-established healthcare systems, and favorable reimbursement policies foster the adoption of nebulizers. Furthermore, in the Middle East and Africa, increased healthcare investment and awareness of respiratory conditions fueling the need for nebulizers.
The APAC region is witnessing a growing need for nebulizers, owing to a large population base, increasing incidence of respiratory ailments, improving healthcare infrastructure, and rising healthcare spending. Countries, including China and India, offer significant opportunities for nebulizer manufacturers owing to the wide availability of economical raw materials and strong manufacturing bases.
Recent Developments
Strategic Partnership Between Onymos and Vapotherm to Advanced Respiratory Management Solutions
Onymos and Vapotherm established a strategic partnership aimed at revolutionizing respiratory care. This partnership is expected to design a cutting-edge digital respiratory platform, specifically for Vapotherm's High-Velocity Therapy (HVT) 2.0 system, enhancing data visualization and device management in acute care settings. Additionally, this partnership paves the way for developing innovative home-based respiratory solutions, signifying a significant step forward in patient care and device management.
Introducing BerryHale the Next-Generation Inhaler with Advanced Dosage Precision for Improved Respiratory Care
Berry Global unveiled the BerryHaler, an innovative dual-chamber inhaler featuring a built-in dose counter. This advanced device is designed to revolutionize the delivery and accessibility of combination medications for patients. Including a dose counter aims to enhance drug administration efficacy by ensuring accurate dosage, aiding in the effective treatment of respiratory conditions. This development signifies a significant advancement in inhaler technology, focusing on improving patient experience and treatment outcomes through more precise and user-friendly medication delivery systems.
Drive DeVilbiss Received 5-Year, USD 13.5 Million Contract with Veteran's Health Administration for Premium Nebulizer System
Drive DeVilbiss Healthcare has secured an exclusive five-year contract with the U.S. Veterans Health Administration (VHA) valued at approximately USD 13.5 million. This contract designates the Drive DeVilbiss Pulmo-Aide Compact Compressor Nebulizer System, alongside its complementary accessories, the Reusable Nebulizer Kit (18254) and Air Inlet Filter (3655D-601), as the VHA's nebulizer of choice across its national network of health centers.
This research report offers invaluable insights into various crucial aspects of the Nebulizer Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 192 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $2.68 Billion |
| Forecasted Market Value (USD) by 2030 | $3.97 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in respiratory diseases and need for nebulizers
5.1.1.2. Growing government initiatives to emphasize respiratory health awareness
5.1.2. Restraints
5.1.2.1. Concerns over potential respiratory infections and availability of alternative drug delivery solutions
5.1.3. Opportunities
5.1.3.1. Continuous advancements and improvements in nebulizer technology
5.1.3.2. Rising adoption of nebulizers in homecare settings
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for nebulizer development and commercialization
5.2. Market Segmentation Analysis
5.2.1. Type: Significant benefits of mesh nebulizers, with compact size, quiet operation, and high medication delivery efficiency
5.2.2. Distribution: Growing preference for online channels due to their broader selection, and the convenience of home delivery
5.2.3. Application: Need for devices capable of handling high-viscosity medications in cystic fibrosis treatments
5.2.4. End-user: High potential of nebulizers in hospitals & clinics for delivering quick and effective medication delivery to patients
5.3. Market Trend Analysis
5.3.1. Robust healthcare framework and frequent innovations to improve the functionality of nebulizers in the Americas region
5.3.2. Robust manufacturing potential for the development of medical devices and increasing government support to improve accessibility of healthcare services in the APAC region
5.3.3. Growing awareness of respiratory health with the presence of major market vendors contributing to the innovation of nebulizers in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Nebulizer Market, by Type
6.1. Introduction
6.2. Jet Nebulizer
6.3. Mesh Nebulizer
6.4. Ultrasonic Nebulizer
7. Nebulizer Market, by Distribution Channel
7.1. Introduction
7.2. Offline
7.3. Online
8. Nebulizer Market, by Application
8.1. Introduction
8.2. Asthma
8.3. COPD
8.4. Cystic Fibrosis
9. Nebulizer Market, by End-user
9.1. Introduction
9.2. Homecare Settings
9.3. Long-Term Healthcare Centers
9.4. Hospitals & Clinics
10. Americas Nebulizer Market
11. Asia-Pacific Nebulizer Market
12. Europe, Middle East & Africa Nebulizer Market
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Strategic Partnership Between Onymos and Vapotherm to Advanced Respiratory Management Solutions
13.3.2. Introducing BerryHale the Next-Generation Inhaler with Advanced Dosage Precision for Improved Respiratory Care
13.3.3. Drive DeVilbiss Received 5-Year, USD 13.5 Million Contract with Veteran's Health Administration for Premium Nebulizer System
13.3.4. Strategic Alliance between AATec Medical and Beurer GmbH to Innovate Respiratory Care
13.3.5. Innovative Collaboration Between Qnovia, Inc. and University of Virginia Targets Inhaled Drug Development For Lung Infections
13.3.6. Phil Inc. Partners with Teva to Enhance Asthma Care Through Innovative Digihaler Technology
13.3.7. Aerogen Joins Forces with Premier, Inc. to Elevate Respiratory Therapy
13.3.8. Introduction of an Innovative Steam Nebulizer by Mypurmist in Australia and New Zealand
13.3.9. Qnovia Secures USD 17 Million Investment to Revolutionize Smoking Cessation With Cutting-edge Nebulizer Technology
13.3.10. Vectura to Open a USD 62 Million Inhalation Research Facility in England by 2025
14. Competitive Portfolio
- 3M
- Aerogen
- Air Liquide Medical Systems
- Andreas Fahl Medizintechnik-Vertrieb
- Becton, Dickinson and Company
- Besco Medical
- Beurer
- BPL Medical Technologies
- Briutcare
- CA-MI
- Cardinal Health
- Contec Medical Systems Co.
- Control D by Haiden Technology
- Drive DeVilbiss International by DeVilbiss Healthcare
- GE HealthCare Technologies Inc.
- GF Health Products, Inc.
- HCmed Innovations Co., Ltd.
- Heyer Medical AG by Beijing Aeonmed Co., Ltd.
- Invacare Corporation
- Koninklijke Philips N.V.
- Lepu Medical Technology(Beijing)Co.,Ltd.
- Medline Industries, LP.
- Medtech Life Pvt. Ltd.
- Medtronic PLC
- MicroGene Diagnostic Systems (P) Ltd
- Microlife
- Nureca
- Omron
- Otica Meditronix
- PARI
- PerkinElmer
- Qnovia
- Renovion
- Rossmax Swiss
- Sunset Healthcare Solutions
- Taidoc Technology
- TEKCELEO SAS
- Teleflex Incorporated
- Thermo Fisher Scientific
- Trudell Medical Group
- Vapore
- Vectura Group Ltd
- Vyaire Medical
For more information about this report visit https://www.researchandmarkets.com/r/wrvgc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
